Dossier
business lines
Coverage of business lines in the Nexus archive.
- Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise
Abbott Laboratories increased its 2026 profit guidance due to a stronger-than-expected second quarter driven by improved performance across most business lines.